NIH Public Access Author Manuscript Leukemia. Author manuscript; available in PMC 2009 July 1.
|
|
- Domenic Cook
- 6 years ago
- Views:
Transcription
1 NIH Public Access Author Manuscript Published in final edited form as: Leukemia January ; 23(1): doi: /leu Asymptomatic Kidney Stones in Long-Term Survivors of Childhood Acute Lymphoblastic Leukemia Sue C. Kaste 1,2,4, Nicole A. Thomas 1, Shesh N. Rai 3, Kyeongmi Cheon 3, Elizabeth McCammon 1, Russell Chesney 5, Deborah Jones 5, Ching-Hon Pui 2, and Melissa M. Hudson 2,5 1Department of Radiological Sciences, Division of Diagnostic Imaging, St. Jude Children's Research Hospital, Memphis Tennessee 2Department of Oncology, St. Jude Children's Research Hospital, Memphis Tennessee 3Department of Biostatistics, St. Jude Children's Research Hospital, Memphis Tennessee 4Department of Radiology, University of Tennessee at Memphis, Memphis Tennessee 5Department of Pediatrics, University of Tennessee at Memphis, Memphis Tennessee Abstract We hypothesized an association between renal calculi and bone mineral density (BMD) deficits, shown in adults, exists in survivors of childhood ALL. Thus, we analyzed associations between quantitative computed tomography (QCT)-determined renal calcifications and clinical parameters (gender, race, age at diagnosis, age at time of QCT), BMD, treatment exposures, Tanner stage. We investigated associations between stone formation and nutritional intake, serum and urinary calcium and creatinine levels, and urinary calcium/creatinine ratio. Exact Chi-square test was used to compare categorical patient characteristics and Wilcoxon-Mann-Whitney test to compare continuous measurements. Of 424 participants, 218 (51.4%) were male; 371 (87.5%) were non-black. Most (n=270; 63.7%) were 3.5 years at ALL diagnosis. Mean (SD) and median (range) BMD Z-scores of the entire cohort was -0.4 (1.2) and -0.5 (-3.9 to 5.1), respectively. Nineteen (10 males; 10 Caucasians) had kidney stones (observed prevalence of 4.5 %; 19/424) with significant negative association between stone formation and body habitus (BMI, p=0.003). Stone formation was associated with treatment protocol (p=0.009) and treatment group (0.007). Thus, kidney stones in childhood ALL survivors could herald future deterioration of renal function and development of hypertension. Long-term follow-up imaging may be warranted in these patients to monitor for progressive morbidity. Keywords asymptomatic kidney stones; bone mineral density; acute lymphoblastic leukemia Correspondence to: Sue C. Kaste. Corresponding author: Dr. Sue C. Kaste, DO Division of Diagnostic Imaging Department of Radiological Sciences St. Jude Children's Research Hospital 332 N. Lauderdale Memphis, TN United States of America Phone: 901/ Fax: 901/ e- mail: sue.kaste@stjude.org.
2 Kaste et al. Page 2 Introduction Methods Statistical Analysis Treatment of acute lymphoblastic leukemia (ALL) with multiagent chemotherapy including glucocorticoid therapy increases a patient's risk for both renal calcifications (1) and reduced BMD (2-4). Both of these conditions are associated with a high rate of bone turnover (5-9). Thus, the finding of one of these entities in a patient may suggest the need to seek the presence of the other. Most available information regarding the association of these conditions is based on adults with symptomatic renal calculi (6;10-15). We hypothesize that a similar association between renal calculi and BMD deficits may also exist in survivors of childhood ALL. In this study, we explore whether there exists a correlation between renal calcifications, identified by quantitative computed tomography (QCT), and low BMD in survivors of childhood ALL. From a large cohort of survivors of childhood ALL (n=424) enrolled on an ongoing IRBapproved interventional trial to improve BMD(16), we identified patients who also had asymptomatic renal calcifications. Renal calcifications were detected by QCT performed for assessment of participants' BMD at the time of enrollment into the study. We analyzed the relationship of stone formation and clinical parameters including gender, race, age at diagnosis, age at time of QCT, raw BMD (in mg/cc), BMD Z-score, treatment exposures, Tanner stage at diagnosis and Tanner stage at the time of QCT. We also investigated the association of renal stones and nutritional calcium, sodium and magnesium intake, serum and urinary calcium and creatinine levels, and urinary calcium/creatinine ratio obtained at study enrollment. All participants, parents, or guardians signed informed consent or assent as appropriate. The study was conducted in compliance with the Health Information Privacy and Accountability Act (HIPAA) of QCT was performed for BMD assessment as previously described (4). With this technique, one-half to two-thirds of the kidneys are visualized on the axial images obtained. Dietary intake of calcium, magnesium and sodium was estimated using the self-administered Block food-frequency questionnaire (FFQ; Block `98 FFQ from at the time of protocol enrollment. The food list used in this questionnaire was developed from the NHANES III dietary recall data ( The nutrient database was developed from the USDA Nutrient Database for Standard Reference. Patients were divided into two groups based on the presence or absence of kidney stones by the QCT scan. To maintain consistency of reporting with our prior ALL survivor studies of BMD, we divided the cohort into two groups depending on the age at time of diagnosis as < 3.5 years versus 3.5 years (4). Exact Chi-square test was used to compare categorical patient characteristics (age groups, treatment, BMI groups, etc.) and the Wilcoxon-Mann-Whitney test was used to compare continuous measurements. Z-score of BMD was categorized as normal versus abnormal, using cut off value of The study cohort was grouped as normal vs overweight vs obese using BMI percentile as delineated in age- and sex-specific growth charts provided by the Centers for Disease Control (threshold for participants under age 18 years: normal- BMI less than the 85 th percentile, overweight- BMI between the 85 th and 95 th percentile, obese- BMI exceeding the 95 th percentile; threshold for participants older than 18 years: normal- BMI less than 25, overweight: between 25 and 30, obese- over 30). The effect of ALL treatment was analyzed
3 Kaste et al. Page 3 Results Discussion by leukemia risk groups (high risk vs low risk) and therapeutic protocols (Table 1). The potential effect of cranial irradiation was analyzed as none, low ( 24 Gy) and high (> 24 Gy). Cumulative incidence function of kidney stones in the study cohort was estimated using the Kalbfleisch-Prentice method (17). The analyses were performed using SAS (SAS Institute, Cary, NC 2003) and Cytel Studio 7 (Cytel, Cambridge, MA) for exact chi-square tests. Of the 424 participants enrolled on the interventional trial (Table 2), 218 (51.4%) were male and 371 (87.5%) were non-black (Hispanics included). The median (range) of time since completion of front-line ALL therapy to the study time was 8.5 years (range, years). The majority of patients (n=270; 63.7%) were 3.5 years of age or older at diagnosis of ALL. The mean (SD) and median (range) BMD Z-scores of the entire cohort (n=424) was -0.4 (1.2) and -0.5 (-3.9 to 5.1), respectively. Nineteen (10 males; 10 Caucasians) of 424 survivors had CT evidence of kidney stones, yielding an overall observed prevalence of 4.5 % (19/424) regardless of the follow-up time. The estimated cumulative incidence of silent kidney stones at 20 years after diagnosis of ALL in this cohort is 24.7% (SD 8.4%) as shown in Figure 1. None of these 19 patients reported a prior history of kidney stones, nor did they report symptoms that could be associated with renal calculi. None of the patients had hematuria detected by urinalysis. Those who developed kidney stones had a mean and median BMD below that of the entire cohort, mg/cc (21.7 mg/ cc) and mg/cc ( mg/cc), respectively (p=0.037; Table 3). Age at diagnosis of leukemia or study, gender or race were not associated with the presence of kidney stones (Table 2). We found a significant negative association between the development of kidney stones and body habitus (BMI, p=0.003). Thus, patients with normal BMI seem to be more likely to develop kidney stones compared with those who had elevated BMI. Stone formation was associated with treatment protocol (p=0.009) and treatment group (0.007) (Table 4). We did not find sufficient evidence for correlation between dose of cranial radiation therapy and kidney stones (Table 4). Nor did we find sufficient evidence for association between kidney stones and urinary calcium/creatinine ratio, serum vitamin D level, fracture history, family history of osteoporosis or renal failure and the development of kidney stones (data not shown). There was no association between kidney stones and use of nutritional supplements (p=0.48). Analysis of nutritional intake of calcium, sodium and magnesium was limited to the 184 of 424 (41%) participants in the study who completed the food frequency questionnaire. Though patients who developed kidney stones consumed lower quantities of calcium, magnesium and sodium, their serum and urinary values were not statistically significantly different from those who did not form kidney stones. We also found no significant association between nutritional intake of calcium, sodium or magnesium and the development of kidney stones (Table 5). The 4.5% prevalence of asymptomatic renal stones in this large cohort of survivors of childhood ALL is almost five times higher than the prevalence of symptomatic renal calcifications of 0.9% we previously reported for pediatric patients treated for ALL (1). As neither study prospectively monitored patients for the occurrence of renal stones, the timing of their development is indeterminate. Not surprisingly, treatment is an important determinant for stone formation. In this regard, none of the patients treated in Total Therapy XII in which glucocorticoid was only used during remission induction, were found to have renal stones. Indeed, none of the 84 (of 424; 19.8%)
4 Kaste et al. Page 4 participants in this study, who had no exposure to glucocorticoids during continuation therapy, developed kidney stones. Corticosteroids are associated with reduced bone formation and loss of mineral from bone. In addition, corticosteroids may reduce gastrointestinal calcium absorption and renal tubular calcium reabsorption, resulting in negative calcium balance (18). The strongest risk factor for developing kidney stones in this cohort was having a normal BMI compared to an overweight/obese BMI. However, weight itself was not significantly related to the formation of kidney stones. Prior adult studies have reported an increased risk of stone formation in individuals with both increased weight (19;20) and with rapid weight loss (21-23). Since we analyzed the BMI status at a single time point, we cannot correlate weight gain or loss with renal stone formation in our study group. Available information regarding the development of renal stones in children and adults has been based on studies of clinically symptomatic cases (1;11;24;25). Renal stones, typically remain unidentified until they cause symptoms (26). Long-term morbidity from kidney stones can be significant and includes hypertension, compromised renal function, pain, and potentially the need for invasive intervention (1;26). The development of renal stones in pediatric patients has been associated with many factors including dietary intake (1), metabolic disorders (24-27) and anatomic abnormalities (24). Other risk factors for kidney stone formation include dehydration (28), infection, immobilization (28), medication use adversely impacting urinary calcium resorption (loop diuretics) (29), inflammatory disorders such as sarcoidosis and juvenile rheumatoid arthritis (29), and bone density loss (1;26). In children with cancer, both tumor lysis syndrome (30) and treatment with glucocorticoids (1) have also been implicated in stone formation. The prevalence of symptomatic kidney stones has been increasing in the general population. A recent study of pediatric renal stones indicated a nearly five-fold increased incidence in symptomatic stones over the past 30 years. VanDervoort et al (25) reported that about 28% of patients were less than 1 year of age at presentation and 76% had at least one abnormality of 24-hour urine collection - most commonly, hypocitraturia. Thus far, the reason for such a dramatic increase remains obscure, but prematurity, furosemide use in infancy and improved ascertainment may be contributing factors (29). We found a negative association between asymptomatic renal calcifications and BMD. In the subset of patients described herein, kidney stones may, in part, be caused by a high rate of bone turnover as has been previously reported in conditions associated with resorptive processes such as those induced by inflammatory mediators (26). Renal calcium wasting also begets BMD deficits in concert with hypercalciuria (26;31) and possibly renal stones, an association that we were unable to confirm. In the general population, children with higher BMD deposit and retain more calcium, resulting in less bone turnover and, possibly associated with fewer renal calcifications. The significant negative relationship we found between BMD and renal calcifications supports this concept. Increased dietary intake of calcium has been shown to be associated with the propensity for stone development, but studies have not conclusively supported the benefits of dietary restriction of calcium in individuals at risk for urolithiasis. Among otherwise healthy adult males, dietary calcium was inversely associated with risk for kidney stones (32). Some studies suggest that a higher calcium intake may reduce the risk for renal stone formation. This surprising finding is likely related to hyperoxaluria resulting from inhibition of intestinal oxalate absorption by dietary calcium, which prevents formation of calcium oxalate stones (33). Higher dietary intake protects skeletal calcium deposits and thus tempers metabolic turnover of calcium, which in turn limits renal clearance of blood calcium. Increased dietary intake of sodium is associated with increased risk for urolithiasis. Urinary calcium excretion
5 Kaste et al. Page 5 Acknowledgements Reference List increases and urinary citrate excretion decreases from baseline when dietary sodium is high (34;35). We failed to find an association between dietary calcium or sodium intake or the use of nutritional supplements and the development of kidney stones. However, as only a small subset (n=184) of the total cohort (n=424) had completed available food frequency questionnaires, ascertainment bias may have contributed to the lack of statistical significance. Several other factors may have contributed to the formation of renal stones in this population of long-term survivors of ALL. Many of the subjects in this series reside in the southeast region of the United States (data not shown) which is often called the stone belt of the U.S. (36). Factors that have been postulated to contribute to stone formation include the higher temperatures, higher humidity with resultant mild dehydration, and higher dietary sodium intake in this region (36). As noted, a high dietary sodium intake has been associated with low bone density and stone formation (7). It is possible that we are detecting clinically silent stones earlier than the general population due to accession through BMD monitoring (31). There are certain limitations with our study. The prospective study (Bone-II trial) was not designed to assess the causative factors in the development of kidney stones, but rather to define BMD status in ALL survivors. No information regarding a family history of kidney stones or familial hypercalciuria was gathered. QCT of the spine showed only a portion (50-67%) of total renal mass, so that information about stone formation in non-imaged portions of the kidneys is unknown. Though we found treatment protocol regimen to be highly significant in the development of kidney stones, we were unable to adequately compare causative roles of individual chemotherapeutic agents due to the complexities of each regimen and potential drug interactions in this small cohort of patients with kidney stones. The presence of kidney stones in survivors of childhood ALL could herald future deterioration of renal function and development of hypertension. Long-term follow-up imaging or urine analysis may be warranted in these patients to monitor for progressive morbidity. We thank Dr. Cheng Cheng for his input regarding statistical analyses and critical editorial review and Sandra Gaither for manuscript preparation. Supported in part by grants P30 CA and P01 CA from the National Institutes of Health, a Center of Excellence grant from the State of Tennessee, and the American Lebanese Syrian Associated Charities (ALSAC). (1). Howard SC, Kaplan SD, Razzouk BI, Rivera GK, Sandlund JT, Ribeiro RC, Rubnitz JE, Gajjar AJ, Ke W, Hancock ML, Skoch JP, Roy S, Hudson M, Pui CH. Urolithiasis in pediatric patients with acute lymphoblastic leukemia. Leukemia 2003;17(3): [PubMed: ] (2). Kaste SC, Rai SN, Fleming K, McCammon EA, Tylavsky FA, Danish RK, Rose SR, Sitter CD, Pui CH, Hudson MM. Changes in bone mineral density in survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 2006;46(1): [PubMed: ] (3). Aisenberg J, Hsieh K, Kalaitzoglou G, Whittam E, Heller G, Schneider R, Sklar C. Bone mineral density in young adult survivors of childhood cancer. J Pediatr Hematol Oncol 1998;20(3): [PubMed: ] (4). Kaste SC, Jones-Wallace D, Rose SR, Boyett JM, Lustig RH, Rivera GK, Pui CH, Hudson MM. Bone mineral decrements in survivors of childhood acute lymphoblastic leukemia: frequency of occurrence and risk factors for their development. Leukemia 2001;15(5): [PubMed: ] (5). Caudarella R, Vescini F, Buffa A, Sinicropi G, Rizzoli E, La Manna G, Stefoni S. Bone mass loss in calcium stone disease: focus on hypercalciuria and metabolic factors. J Nephrol 2003;16(2): [PubMed: ]
6 Kaste et al. Page 6 (6). Lauderdale DS, Thisted RA, Wen M, Favus MJ. Bone mineral density and fracture among prevalent kidney stone cases in the Third National Health and Nutrition Examination Survey. J Bone Miner Res 2001;16(10): [PubMed: ] (7). Martini LA, Cuppari L, Colugnati FA, Sigulem DM, Szejnfeld VL, Schor N, Heilberg IP. High sodium chloride intake is associated with low bone density in calcium stone-forming patients. Clin Nephrol 2000;54(2): [PubMed: ] (8). Pietschmann F, Breslau NA, Pak CY. Reduced vertebral bone density in hypercalciuric nephrolithiasis. J Bone Miner Res 1992;7(12): [PubMed: ] (9). Weisinger JR. Bone loss in hypercalciuria: cause or consequence? Am J Kidney Dis 1999;33(1):xlvi xlviii. [PubMed: ] (10). de Lorimier AA. Alcohol, wine, and health. Am J Surg 2000;180(5): [PubMed: ] (11). Tsuji H, Umekawa T, Kurita T, Uemura H, Iguchi M, Kin K, Kushida K. Analysis of bone mineral density in urolithiasis patients. Int J Urol 2005;12(4): [PubMed: ] (12). Sowers MR, Jannausch M, Wood C, Pope SK, Lachance LL, Peterson B. Prevalence of renal stones in a population-based study with dietary calcium, oxalate, and medication exposures. Am J Epidemiol 1998;147(10): [PubMed: ] (13). Gerster H. No contribution of ascorbic acid to renal calcium oxalate stones. Ann Nutr Metab 1997;41 (5): [PubMed: ] (14). Tasca A, Cacciola A, Ferrarese P, Ioverno E, Visona E, Bernardi C, Nobile M, Giannini S. Bone alterations in patients with idiopathic hypercalciuria and calcium nephrolithiasis. Urology 2002;59 (6): [PubMed: ] (15). Asplin JR, Bauer KA, Kinder J, Muller G, Coe BJ, Parks JH, Coe FL. Bone mineral density and urine calcium excretion among subjects with and without nephrolithiasis. Kidney Int 2003;63(2): [PubMed: ] (16). Crom DB, Tyc VL, Rai SN, Deng X, Hudson MM, Booth A, Rodrigues LN, Zhang L, McCammon E, Kaste SC. Retention of survivors of acute lymphoblastic leukemia in a longitudinal study of bone mineral density. J Child Health Care 2006;10(4): [PubMed: ] (17). Kalbfleisch, JD.; Prentice, RL. The Statistical Analysis of Failure Time Data. Vol. 2nd ed.. John Wiley & Sons, Inc; Hoboken, NJ: (18). Ward, LM.; Glorieux, FH. The spectrum of pediatric osteoporosis. In: Glorieux, FH., editor. Pediatric Bone: Biology and Diseases. Academic Press; San Diego, CA: p (19). Taylor EN, Curhan GC. Body size and 24-hour urine composition. Am J Kidney Dis 2006;48(6): [PubMed: ] (20). Taylor EN, Stampfer MJ, Curhan GC. Obesity, weight gain, and the risk of kidney stones. JAMA 2005;293(4): [PubMed: ] (21). Annuk M, Backman U, Holmgren K, Vessby B. Urinary calculi and jejunoileal bypass operation. A long-term follow-up. Scand J Urol Nephrol 1998;32(3): [PubMed: ] (22). Hocking MP, Duerson MC, O'Leary JP, Woodward ER. Jejunoileal bypass for morbid obesity. Late follow-up in 100 cases. N Engl J Med 1983;308(17): [PubMed: ] (23). Breaux CW. Obesity Surgery in Children. Obes Surg 1995;5(3): [PubMed: ] (24). Schwarz RD, Dwyer NT. Pediatric kidney stones: long-term outcomes. Urology 2006;67(4): [PubMed: ] (25). VanDervoort K, Wiesen J, Frank R, Vento S, Crosby V, Chandra M, Trachtman H. Urolithiasis in pediatric patients: a single center study of incidence, clinical presentation and outcome. J Urol 2007;177(6): [PubMed: ] (26). Cameron MA, Sakhaee K, Moe OW. Nephrolithiasis in children. Pediatr Nephrol 2005;20(11): [PubMed: ] (27). Moxey-Mims MM, Stapleton FB. Hypercalciuria and nephrocalcinosis in children. Curr Opin Pediatr 1993;5(2): [PubMed: ] (28). Marangella M. Uric acid elimination in the urine. Pathophysiological implications. Contrib Nephrol 2005;147: [PubMed: ] (29). Stapleton FB. Nephrolithiasis in children. Pediatr Rev 1989;11(1): [PubMed: ]
7 Kaste et al. Page 7 (30). LaRosa C, McMullen L, Bakdash S, Ellis D, Krishnamurti L, Wu HY, Moritz ML. Acute renal failure from xanthine nephropathy during management of acute leukemia. Pediatr Nephrol 2007;22 (1): [PubMed: ] (31). Garcia-Nieto V, Navarro JF, Monge M, Garcia-Rodriguez VE. Bone mineral density in girls and their mothers with idiopathic hypercalciuria. Nephron Clin Pract 2003;94(4):c89 c93. [PubMed: ] (32). Curhan GC, Willett WC, Rimm EB, Stampfer MJ. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med 1993;328(12): [PubMed: ] (33). Borghi L, Schianchi T, Meschi T, Guerra A, Allegri F, Maggiore U, Novarini A. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med 2002;346 (2): [PubMed: ] (34). Sakhaee K, Harvey JA, Padalino PK, Whitson P, Pak CY. The potential role of salt abuse on the risk for kidney stone formation. J Urol 1993;150(2 Pt 1): [PubMed: ] (35). Breslau NA, McGuire JL, Zerwekh JE, Pak CY. The role of dietary sodium on renal excretion and intestinal absorption of calcium and on vitamin D metabolism. J Clin Endocrinol Metab 1982;55 (2): [PubMed: ] (36). Thun MJ, Schober S. Urolithiasis in Tennessee: an occupational window into a regional problem. Am J Public Health 1991;81(5): [PubMed: ]
8 Kaste et al. Page 8 Figure 1. Curve indicating cumulative incidence of kidney stone in the study cohort, estimated to be 24.7% (SD 8.4%) at 20 years from diagnosis.
9 Kaste et al. Page 9 Table 1 Summary of Post-Remission (Continuation) Therapy in Total Therapy Studies XI-XIII. Protocol Era Total patients enrolled Preventive CNS Therapy Continuation therapy * Total XI All patients triple IT for first year Cranial RT at 1 y post CR for Worse risk (18 Gy) and CNS disease at diagnosis (24 Gy) 6-MP, MTX, PDN, VCR (39 lower-risk cases) cyclophosphamide+ etoposide, cytarabine + teniposide, 6-MP + MTX, PDN + VCR (the remaining patients) Total XII Similar to XI Cytarabine, 6-MP, MTX, teniposide Total XIII Low risk Total XIII High risk IT chemotherapy only * Asparaginase, DEX or PDN, 6- MP, MTX, VCR Similar to XI Etoposide + Cyclophosphamide, 6-MP + MTX, MTX + cytarabine, etoposide + cytarabine, DEX + VCR * 18 Gy cranial radiation therapy received for very high-risk patients (e.g. leukemia involvement of cranial nerves at diagnosis).
10 Kaste et al. Page 10 Table 2 Patient characteristics by detection of kidney stone Kidney stones Factors Overall (%) Yes (%) No (%) P-Value Age at Diagnosis 0.47 >= (63.7) 14 (73.7) 256 (63.3) < 3.5 yr 154 (36.3) 5 (26.3) 149 (36.7) Age at Study (23.1) 4 (21.1) 94 (23.2) (26.4) 5 (26.3) 107 (26.4) (23.8) 2 (10.5) 99 (24.4) > (26.7) 8 (42.1) 105 (25.9) Gender 1.00 Female 206 (48.6) 9 (47.4) 197 (48.6) Male 218 (51.4) 10 (52.6) 208 (51.4) BMI Normal 199 (46.9) 16 (84.2) 183 (45.2) Overweight 95 (22.4) 2 (10.5) 93 (23.0) Obese 130 (30.7) 1 (5.3) 129 (31.9) Race 0.15 Black 53 (12.5) 0 (0.0) 53 (13.1) Other 371 (87.5) 19 (100.0) 352 (86.9)
11 Kaste et al. Page 11 Table 3 Continuous measurements of factors that may contribute to kidney stone formation Kidney Stone (Yes) Kidney Stone (No) All Factor Median (Min-Max) Median (Min-Max) Median (Min-Max) P-value Age at Diagnosis (years) 6.6 ( ) 4.4 ( ) 4.6 ( ) 0.12 Age at Study (years) 21.2 ( ) 17.0 ( ) 17.0 ( ) 0.29 Height (cm) ( ) ( ) ( ) 0.75 Weight (kg) 57.5 ( ) 63.6 ( ) 63.3 ( ) 0.10 BMI 20.9 ( ) 24.1 ( ) 24.0 ( ) Dietary Calcium (mg/day) ( ) ( ) ( ) 0.42 Dietary Magnesium (mg/day) ( ) ( ) ( ) 0.37 Dietary Sodium (mg/day) ( ) ( ) ( ) Serum Calcium/ Creatinine Ratio 11.1 ( ) 12.7 ( ) 12.6 ( ) 0.51 Serum BUN (mg/dl) 12.0 ( ) 12.0 ( ) 12.0 ( ) 0.92 Serum Calcium (mg/dl) 9.4 ( ) 9.3 ( ) 9.3 ( ) 0.27 Serum Creatinine (mg/dl) 0.8 ( ) 0.7 ( ) 0.7 ( ) 0.41 Serum Magnesium (meq/l) 1.7 ( ) 1.6 ( ) 1.7 ( ) 0.13 Urinary Calcium / Creatinine Ratio 0.1 ( ) 0.1 ( ) 0.1 ( ) 0.13 Urinary Calcium (mg/dl) 16.5 ( ) 13.1 ( ) 13.3 ( ) 0.30 Urinary Creatinine (mg/dl) ( ) ( ) ( ) 0.55 Urinary Sodium (mmol/l) ( ) ( ) ( ) 0.58 Urinary Sodium /Urinary Creatinine Ratio 1.3 ( ) 1.2 ( ) 1.2 ( ) 0.48 BMD (mg/cc) ( ) ( ) ( ) Z-Score -1.0 ( ) -0.5 ( ) -0.5 ( ) Time from Diagnosis to Study (years) 8.6 ( ) 10.9 ( ) 10.6 ( ) 0.57
12 Kaste et al. Page 12 Treatment of ALL by detection of kidney stone Table 4 kidney stones Factors Overall (%) Yes (%) No (%) P-Value Therapeutic Protocol Total (33.0) 7 (36.8) 133 (32.8) Total (19.8) 0 (0.0) 84 (20.7) Total (22.2) 2 (10.5) 92 (22.7) Total 13B 106 (25.0) 10 (52.6) 96 (23.7) Risk Group 0.22 High 266 (62.7) 9 (47.4) 257 (63.5) Low 158 (37.3) 10 (52.6) 148 (36.5) Protocol/Risk H 86 (20.3) 3 (15.8) 83 (20.5) 11L 54 (12.7) 4 (21.1) 50 (12.3) 12H 45 (10.6) 0 (0.0) 45 (11.1) 12L 39 (9.2) 0 (0.0) 39 (9.6) 13BL 53 (12.5) 4 (21.1) 49 (12.1) 13BH 53 (12.5) 6 (31.6) 47 (11.6) 13H 82 (19.3) 0 (0.0) 82 (20.2) 13L 12 (2.8) 2 (10.5) 10 (2.5) Radiation Therapy 0.40 High 35 (8.3) 0 (0.0) 35 (8.6) Low 115 (27.1) 5 (26.3) 110 (27.2) None 274 (64.6) 14 (73.7) 260 (64.2)
13 Kaste et al. Page 13 Table 5 Nutrition intake questionnaire by detection of kidney stone kidney stones Factors Overall (%) Yes (%) No (%) P-Value Dietary Calcium 1.00 Low 127 (69.0) 10 (71.4) 117 (68.8) Normal 57 (31.0) 4 (28.6) 53 (31.2) Dietary Magnesium 0.78 Low 123 (66.8) 10 (71.4) 113 (66.5) Normal 61 (33.2) 4 (28.6) 57 (33.5) Dietary Sodium Low 29 (15.8) 3 (21.4) 26 (15.3) 0.70 Normal 155 (84.2) 11 (78.6) 144 (84.7) Supplements 0.48 Yes 185 (43.6) 10 (52.6) 175 (43.2) No 239 (56.4) 9 (47.4) 230 (56.8)
Calcium Nephrolithiasis and Bone Health. Noah S. Schenkman, MD
Calcium Nephrolithiasis and Bone Health Noah S. Schenkman, MD Associate Professor of Urology and Residency Program Director, University of Virginia Health System; Charlottesville, Virginia Objectives:
More informationDiet and fluid prescription in stone disease
http://www.kidney-international.org & 2006 International Society of Nephrology mini review Diet and fluid prescription in stone disease EN Taylor 1 and GC Curhan 1,2 1 Renal Division, Department of Medicine,
More informationRISK FACTORS AND TREATMENT STRATEGIES FOR URINARY STONES Review of NASA s Evidence Reports on Human Health Risks
Mayo Clinic O Brien Urology Research Center RISK FACTORS AND TREATMENT STRATEGIES FOR URINARY STONES 2017 Review of NASA s Evidence Reports on Human Health Risks John C Lieske, MD July 27, 2017 What types
More informationEffects of dietary interventions on 24-hour urine parameters in patients with idiopathic recurrent calcium oxalate stones
Kaohsiung Journal of Medical Sciences (2013) 29, 88e92 Available online at www.sciencedirect.com journal homepage: http://www.kjms-online.com ORIGINAL ARTICLE Effects of dietary interventions on 24-hour
More informationMEDICAL STONE MANAGEMENT MADE EASY PRACTICAL ADVICE
MEDICAL STONE MANAGEMENT MADE EASY PRACTICAL ADVICE Comprehensive Kidney Stone Center at Duke University Medical Center Durham, North Carolina Glenn M. Preminger, M.D. UCLA State-of-the Art Urology 02
More information4/3/2015. Obesity in Childhood Cancer Survivors: Opportunities for Early Intervention. Cancer in Children. Cancer is the #1 cause of diseaserelated
Obesity in Childhood Cancer Survivors: Opportunities for Early Intervention Fang Fang Zhang, MD, PhD Friedman School of Nutrition Science and Policy, Tufts University UNTHSC Grant Rounds April 8, 2015
More informationEvaluation of the Recurrent Stone Former
Urol Clin N Am 34 (2007) 315 322 Evaluation of the Recurrent Stone Former Paramjit S. Chandhoke, MD, PhD* Department of Urology, Northwest Permanente, Portland, OR, USA At one time, metabolic kidney stone
More information24-h uric acid excretion and the risk of kidney stones
http://www.kidney-international.org & 2008 International Society of Nephrology original article 24-h uric acid excretion and the risk of kidney stones GC Curhan 1,2,3 and EN Taylor 1,2 1 Department of
More informationQuality of life and urolithiasis: the patient - reported outcomes measurement information system (PROMIS)
ORIGINAL ARTICLE Vol. 43 (5): 880-886, September - October, 2017 doi: 10.1590/S1677-5538.IBJU.2016.0649 Quality of life and urolithiasis: the patient - reported outcomes measurement information system
More informationMedical Approach to Nephrolithiasis. Seth Goldberg, MD September 15, 2017 ACP Meeting
Medical Approach to Nephrolithiasis Seth Goldberg, MD September 15, 2017 ACP Meeting DISCLOSURES Seth Goldberg, MD Assistant Professor of Medicine Research support Abbott Kadmon Otsuka Pfizer Introduction
More informationApproximately 80% of kidney stones contain calcium,
Determinants of 24-hour Urinary Oxalate Excretion Eric N. Taylor* and Gary C. Curhan* *Renal Division and Channing Laboratory, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School,
More informationA Prospective Study of Risk Factors for Nephrolithiasis After Roux-en-Y Gastric Bypass Surgery
A Prospective Study of Risk Factors for Nephrolithiasis After Roux-en-Y Gastric Bypass Surgery Alyssa M. Park,* Douglas W. Storm, Brant R. Fulmer, Christopher D. Still, G. Craig Wood and James E. Hartle,
More information24 HOUR URINARY METABOLIC PROFILE AFTER PERCUTANEOUS NEPHROLITHOTOMY
Original Article Urology 24 HOUR URINARY METABOLIC PROFILE AFTER PERCUTANEOUS NEPHROLITHOTOMY Sreedhar Dayapule 1, Suryaprakash Vaddi 1, Vijaya Bhaskar G 1, Ramamohan Pathapati 2 1 - Assistant Professor,
More informationEffect of calcium intake on urinary oxalate excretion in calcium stone-forming patients
Brazilian Journal of Medical and Biological Research (2002) 35: 669-675 Calcium intake and oxalate excretion ISSN 0100-879X 669 Effect of calcium intake on urinary oxalate excretion in calcium stone-forming
More informationARIC Manuscript Proposal # 1518
ARIC Manuscript Proposal # 1518 PC Reviewed: 5/12/09 Status: A Priority: 2 SC Reviewed: Status: Priority: 1. a. Full Title: Prevalence of kidney stones and incidence of kidney stone hospitalization in
More informationHypercalcemia. Hypercalcemia: When to Worry, When to Treat! Mineral Metabolism : A Short Course
Hypercalcemia: When to Worry, When to Treat! Michael A. Levine has no financial relationships to disclose or Conflicts of Interest to resolve. Michael A. Levine, M.D. This presentation will not involve
More informationFamily History and Age at the Onset of Upper Urinary Tract Calculi
Endourology and Stone Disease Family History and Age at the Onset of Upper Urinary Tract Calculi Yadollah Ahmadi Asr Badr, Samad Hazhir, Kamaleddin Hasanzadeh Introduction: The aim of this study was to
More informationBisphosphonates in the management of idiopathic hypercalciuria associated with osteoporosis: a new trick from an old drug
Therapeutic Advances in Musculoskeletal Disease Review Bisphosphonates in the management of idiopathic hypercalciuria associated with osteoporosis: a new trick from an old drug Ther Adv Musculoskel Dis
More informationIdiopathic Hypercalciuria in Iranian Children
Short Communication Iran J Pediatr Jun 2008; Vol 18 ( No 2), Pp:163-166 Idiopathic Hypercalciuria in Iranian Children Ali Ahmadzadeh* 1, MD, Pediatrician; Mehran Hakimzadeh 1, MD, Pediatrician; Arezoo
More informationBODY SIZE plays an important role in nephrolithiasis.
Body Size and 24-Hour Urine Composition Eric N. Taylor, MD, and Gary C. Curhan, MD, ScD Background: Greater body mass index (BMI) is a risk factor for kidney stones. However, the relation between BMI and
More informationThe Dietary Approaches to Stop Hypertension (DASH)
CJASN epress. Published on September 16, 2010 as doi: 10.2215/CJN.04420510 DASH-Style Diet and 24-Hour Urine Composition Eric N. Taylor,* Meir J. Stampfer,* David B. Mount, and Gary C. Curhan* *Channing
More informationSchool of Medicine and Health Sciences Division of Basic Medical Sciences Discipline of Biochemistry and Molecular Biology PLB SEMINAR
1 School of Medicine and Health Sciences Division of Basic Medical Sciences Discipline of Biochemistry and Molecular Biology PLB SEMINAR URINARY (RENAL) STONE FORMATION An Overview What are Urinary (Renal)
More informationDietary Management of Nephrolithiasis. Sarah Yttri, NP Duke University Duke Comprehensive Kidney Stone Center
Dietary Management of Nephrolithiasis Sarah Yttri, NP Duke University Duke Comprehensive Kidney Stone Center None Disclosures Prevalence 1 in 11 individuals in the US 10.6% of men, 7.1% of women 70% increase
More informationBone and Metabolic Markers in Women With Recurrent Calcium Stones
www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.3.177 Endourology/Urolithiasis Bone and Metabolic Markers in Women With Recurrent Calcium Stones Miguel Angel Arrabal-Polo, Miguel Arrabal-Martin,
More informationDeterminants of Osteopenia in Male Renal-Stone Disease Patients with Idiopathic Hypercalciuria
Article Determinants of Osteopenia in Male Renal-Stone Disease Patients with Idiopathic Hypercalciuria Emmanuel Letavernier,* Olivier Traxer, Michel Daudon, Mohammed Tligui, Jérôme Hubert-Brierre, Dominique
More informationEQUILIBRIUM VERSUS SUPERSATURATED URINE HYPOTHESIS IN CALCIUM SALT UROLITHIASIS: A NEW THEORETICAL AND PRACTICAL APPROACH TO A CLINICAL PROBLEM
Scanning Microscopy Vol. 13, No. 2-3, 1999 (Pages 261-265) 0891-7035/99$5.00+.25 Scanning Microscopy International, Chicago Equilibrium (AMF O Hare), model for IL calcium 60666 USA salt urolithiasis EQUILIBRIUM
More informationReviews in Clinical Medicine
Mashhad University of Medical Sciences (MUMS) Reviews in Clinical Medicine Clinical Research Development Center Ghaem Hospital Evaluation of the effects of magnesium supplement in primary and secondary
More informationDiabetes mellitus and the risk of nephrolithiasis
Kidney International, Vol. 68 (2005), pp. 1230 1235 Diabetes mellitus and the risk of nephrolithiasis ERIC N. TAYLOR, 1 MEIR J. STAMPFER, 2 and GARY C. CURHAN 1 Channing Laboratory, and Renal Division,
More informationMetabolic Stone Work-Up For Stone Prevention. Dr. Hazem Elmansy, MD, MSC, FRCSC Assistant Professor, NOSM, Urology Department
Metabolic Stone Work-Up For Stone Prevention Dr. Hazem Elmansy, MD, MSC, FRCSC Assistant Professor, NOSM, Urology Department Faculty/Presenter Disclosure Slide Faculty: Hazem Elmansy Relationships with
More informationPrevention of recurrent calcium stones in adults
Official reprint from UpToDate www.uptodate.com Print Back Prevention of recurrent calcium stones in adults Author Gary C Curhan, MD, ScD Section Editor Stanley Goldfarb, MD Deputy Editor Theodore W Post,
More informationThe effect of supplementation with vitamin D on recurrent ischemic events and sudden cardiac death in patients with acute coronary syndrome
CRC IRB Proposal Matthew Champion PGY-1 8/29/12 The effect of supplementation with vitamin D on recurrent ischemic events and sudden cardiac death in patients with acute coronary syndrome Study Purpose
More informationThis is the written version of our Hot Topic video presentation available at: MayoMedicalLaboratories.com/hot-topics
This is the written version of our Hot Topic video presentation available at: MayoMedicalLaboratories.com/hot-topics Welcome to Mayo Medical Laboratories Hot Topics. These presentations provide short discussion
More informationHyperparathyroidism: Operative Considerations. Financial Disclosures: None. Hyperparathyroidism. Hyperparathyroidism 11/10/2012
Hyperparathyroidism: Operative Considerations Financial Disclosures: None Steven J Wang, MD FACS Associate Professor Dept of Otolaryngology-Head and Neck Surgery University of California, San Francisco
More informationRecurrent stone formers-metabolic evaluation: a must investigation
International Surgery Journal Bhangu GS et al. Int Surg J. 2017 Jan;4(1):86-90 http://www.ijsurgery.com pissn 2349-3305 eissn 2349-2902 Original Research Article DOI: http://dx.doi.org/10.18203/2349-2902.isj20163972
More informationEffect of BMI and Urinary ph on Urolithiasis and Its Composition
Saudi J Kidney Dis Transpl 2013;24(1):60-66 2013 Saudi Center for Organ Transplantation Original Article Saudi Journal of Kidney Diseases and Transplantation Effect of BMI and Urinary ph on Urolithiasis
More informationPart I: On-line web-based survey of Dalmatian owners GENERAL INFORMATION
Dr. Bartges' final report on the Dal stone survey: Commissioned by the Dalmatian Club of America Foundation (DCAF) Published in the DCA magazine, The Spotter, Summer 2006 Part I: On-line web-based survey
More informationUrinary Lithiasis and Idiopathic Hypercalciuria: The Importance of Dietary Intake Evaluation
Clinical Urology Dietary Intake in Idiopathic Hypercalciuria International Braz J Urol Vol. 36 (5): 557-562, September - October, 2010 doi: 10.1590/S1677-55382010000500005 Urinary Lithiasis and Idiopathic
More informationKIDNEY STONES ARE A MAJOR
ORIGINAL CONTRIBUTION Obesity, Weight Gain, and the Risk of Kidney Stones Eric N. Taylor, MD Meir J. Stampfer, MD, DrPH Gary C. Curhan, MD, ScD Context Larger body size may result in increased urinary
More informationCalcium nephrolithiasis and bone demineralization: pathophysiology, diagnosis, and medical management
REVIEW C URRENT OPINION Calcium nephrolithiasis and bone demineralization: pathophysiology, diagnosis, and medical management Miguel A. Arrabal-Polo a, María del Carmen Cano-García a, Benjamin K. Canales
More informationNIH Public Access Author Manuscript Eur Urol. Author manuscript; available in PMC 2013 July 01.
NIH Public Access Author Manuscript Published in final edited form as: Eur Urol. 2012 July ; 62(1): 160 165. doi:10.1016/j.eururo.2012.03.052. Prevalence of Kidney Stones in the United States Charles D.
More informationPrevalence of Symptomatic Urinary Calculi in Kerman, Iran
Endourology and Stone Disease Prevalence of Symptomatic Urinary Calculi in Kerman, Iran Ali Asghar Ketabchi, Gholam Abbas Aziziolahi Keywords: urinary calculi, Iran, epidemiology, occupations, substance-related
More informationManagement of common uroliths through diet
Vet Times The website for the veterinary profession https://www.vettimes.co.uk Management of common uroliths through diet Author : Marge Chandler Categories : Canine, Companion animal, Feline, Vets Date
More informationUC San Francisco UC San Francisco Previously Published Works
UC San Francisco UC San Francisco Previously Published Works Title Effect of Diet Orange soda on urinary lithogenicity Permalink https://escholarship.org/uc/item/27x8w1h4 Journal Urological Research, 40(3)
More informationNEPHROLITHIASIS Etiology, stone composition, medical management, and prevention
NEPHROLITHIASIS Etiology, stone composition, medical management, and prevention Urology Division, Surgery Department Medical Faculty, University of Sumatera Utara Epidemiology Prevalence 2-3%, maybe in
More informationKidney Stone Update. Epidemiology of Kidney Stones. Lifetime Risk of Kidney Stone
Kidney Stone Update Michael Emmett MD Baylor University Medical Center Dallas, Texas Epidemiology of Kidney Stones Incidence About 0.3% Prevalence 10% Men 12% Women 8% Hospitalization Peak Age Stone Composition
More informationHYPERCALCEMIA. Babak Tamizi Far MD. Assistant professor of internal medicine Al-zahra hospital, Isfahan university of medical sciences
HYPERCALCEMIA Babak Tamizi Far MD. Assistant professor of internal medicine Al-zahra hospital, Isfahan university of medical sciences ESSENTIALS OF DIAGNOSIS Serum calcium level > 10.5 mg/dl Serum ionized
More informationMetabolic Abnormalities Associated With Renal Calculi in Patients with Horseshoe Kidneys
JOURNAL OF ENDOUROLOGY Volume 18, Number 2, March 2004 Mary Ann Liebert, Inc. Metabolic Abnormalities Associated With Renal Calculi in Patients with Horseshoe Kidneys GANESH V. RAJ, M.D., 1 BRIAN K. AUGE,
More informationAlkaline citrate reduces stone recurrence and regrowth after shockwave lithotripsy and percutaneous nephrolithotomy
Clinical Urology Alkaline citrate and stone recurrence International Braz J Urol Vol. 37 (5): 611-616, September - October, 2011 Alkaline citrate reduces stone recurrence and regrowth after shockwave lithotripsy
More informationNomogram to predict uric acid kidney stones based on patient s age, BMI and 24-hour urine profiles: A multicentre validation
ORIGINAL RESEARCH Nomogram to predict uric acid kidney stones based on patient s age, BMI and 24-hour urine profiles: A multicentre validation Fabio Cesar Miranda Torricelli, MD; * Robert Brown, MD; Fernanda
More information2015 OPSC Annual Convention. syllabus. February 4-8, 2015 Hyatt Regency Mission Bay San Diego, California
2015 OPSC Annual Convention syllabus February 4-8, 2015 Hyatt Regency Mission Bay San Diego, California FRIDAY, FEBRUARY 6, 2015: 4:00pm - 5:00pm Stone Disease^ Presented by John Grimaldi, DO ^ California
More informationOxalate Intake and the Risk for Nephrolithiasis
Oxalate Intake and the Risk for Nephrolithiasis Eric N. Taylor* and Gary C. Curhan* *Renal Division and Channing Laboratory, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School,
More informationSYSTEMIC IMPLICATIONS OF NEPHROLITHIASIS
SYSTEMIC IMPLICATIONS OF NEPHROLITHIASIS Marshall L. Stoller, M.D. Professor and Vice Chairman Department of Urology University of California San Francisco A STONE IS A STONE IS A STONE OR IS IT????? PATIENT
More informationEvaluation of different urinary constituent ratios in renal stone formers
Available online at www.scholarsresearchlibrary.com Annals of Biological Research, 2010, 1 (3) : 50-55 (http://scholarsresearchlibrary.com/archive.html) ISSN 0976-1233 CODEN (USA): ABRNBW Evaluation of
More informationThe Nuts and Bolts of Kidney Stones. Soha Zouwail Consultant Chemical Pathology UHW Renal Training Day 2019
The Nuts and Bolts of Kidney Stones Soha Zouwail Consultant Chemical Pathology UHW Renal Training Day 2019 Urinary Calculi Prevalence and incidence of kidney stones increasing across the world Environmental
More informationIdiopathic hypercalciuria: Can we prevent stones and protect bones?
REVIEW LEARNING OBJECTIVE: Readers will evaluate hypercalciuria in the context of bone health LAURA E. RYAN, MD Clinical Associate Professor of Medicine, Division of Endocrinology, Diabetes, and Metabolism,
More informationThe Skeletal Response to Aging: There s No Bones About It!
The Skeletal Response to Aging: There s No Bones About It! April 7, 2001 Joseph E. Zerwekh, Ph.D. Interrelationship of Intestinal, Skeletal, and Renal Systems to the Overall Maintenance of Normal Calcium
More informationNon-protein nitrogenous substances (NPN)
Non-protein nitrogenous substances (NPN) A simple, inexpensive screening test a routine urinalysis is often the first test conducted if kidney problems are suspected. A small, randomly collected urine
More informationEfficacy of risedronate in men with primary and secondary osteoporosis: results of a 1-year study
Rheumatol Int (2006) 26: 427 431 DOI 10.1007/s00296-005-0004-4 ORIGINAL ARTICLE J. D. Ringe Æ H. Faber Æ P. Farahmand Æ A. Dorst Efficacy of risedronate in men with primary and secondary osteoporosis:
More informationEffect of Potassium Magnesium Citrate and Vitamin B-6 Prophylaxis for Recurrent and Multiple Calcium Oxalate and Phosphate Urolithiasis
www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.6.411 Original Article - Endourology/Urolithiasis http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.6.411&domain=pdf&date_stamp=2014-06-16
More informationPharmacological Treatment of Endocrinopathies
Pharmacological Treatment of Endocrinopathies Progress in Basic and Clinical Pharmacology Vol. 5 Series Editors P. Lomax, Los Angeles, Calif. E.S. Vesell, Hershey, Pa. KARGER Basel München Paris. London
More informationBMD: A Continuum of Risk WHO Bone Density Criteria
Pathogenesis of Osteoporosis Osteoporosis Diagnosis: BMD, FRAX and Assessment of Secondary Osteoporosis AGING MENOPAUSE OTHER RISK FACTORS RESORPTION > FORMATION Bone Loss LOW PEAK BONE MASS Steven T Harris
More informationHypercalciuria is a common and important finding in postmenopausal women with osteoporosis
European Journal of Endocrinology (2003) 149 209 213 ISSN 0804-4643 CLINCAL STUDY Hypercalciuria is a common and important finding in postmenopausal women with osteoporosis Sandro Giannini 1,2, Martino
More informationNATIONAL KIDNEY MONTH
NATIONAL KIDNEY MONTH According to the WebMD website, kidneys have several specific roles: Maintain your body s balance of water and concentration of minerals, such as sodium, potassium, magnesium and
More informationUsing the FRAX Tool. Osteoporosis Definition
How long will your bones remain standing? Using the FRAX Tool Gary Salzman M.D. Director Banner Good Samaritan/ Hayden VAMC Internal Medicine Geriatric Fellowship Program Phoenix, Arizona Using the FRAX
More informationThe New England Journal of Medicine
The New England Journal of Medicine Copyright 2002 by the Massachusetts Medical Society VOLUME 346 J ANUARY 10, 2002 NUMBER 2 COMPARISON OF TWO DIETS FOR THE PREVENTION OF RECURRENT STONES IN IDIOPATHIC
More informationSkeletal Manifestations
Skeletal Manifestations of Metabolic Bone Disease Mishaela R. Rubin, MD February 21, 2008 The Three Ages of Women Gustav Klimt 1905 1 Lecture Outline Osteoporosis epidemiology diagnosis secondary causes
More informationFit4Life: A weight management program for young cancer survivors. Jeannie Huang, MD, MPH University of California San Diego October, 2014
Fit4Life: A weight management program for young cancer survivors Jeannie Huang, MD, MPH University of California San Diego October, 2014 Disclosures I have no relevant disclosures Objectives To review
More informationFirst relapsed childhood ALL Role of chemotherapy
First relapsed childhood ALL Role of chemotherapy Thirachit Chotsampancharoen, M.D. Division of Pediatric Hematology/Oncology Department of Pediatrics Prince of Songkla University Hat-Yai, Songkhla 25
More informationNIH Public Access Author Manuscript Endocr Pract. Author manuscript; available in PMC 2014 May 11.
NIH Public Access Author Manuscript Published in final edited form as: Endocr Pract. 2013 ; 19(5): 780 784. doi:10.4158/ep12416.or. FRAX Prediction Without BMD for Assessment of Osteoporotic Fracture Risk
More informationProphylactic Cranial Irradiation in Acute Lymphoblastic Leukemia: Is there still an indication? Celine Bicquart, MD Radiation Medicine May 5, 2010
Prophylactic Cranial Irradiation in Acute Lymphoblastic Leukemia: Is there still an indication? Celine Bicquart, MD Radiation Medicine May 5, 2010 Outline Epidemiology Risk-groups Background & Rationale
More informationRenal Data from Asia Africa
Saudi J Kidney Dis Transpl 2013;24(4):838-843 2013 Saudi Center for Organ Transplantation Saudi Journal of Kidney Diseases and Transplantation Renal Data from Asia Africa Metabolic Evaluation in First-Time
More informationMETABOLIC ASSESSMENT IN PATIENTS WITH URINARY LITHIASIS
Clinical Urology International Braz J Urol Official Journal of the Brazilian Society of Urology Vol. 31(1): 29-33, January - February, 2005 METABOLIC ASSESSMENT IN PATIENTS WITH URINARY LITHIASIS CARMEN
More informationUrolithiasis/Endourology
Urolithiasis/Endourology Dietary Intake of Fiber, Fruit and Vegetables Decreases the Risk of Incident Kidney Stones in Women: A Women s Health Initiative Report Mathew D. Sorensen,*, Ryan S. Hsi, Thomas
More informationUrinary stone distribution in Samawah: current status and variation with age and sex a cohort study
www.muthjm.com Muthanna Medical Journal 2015; 2(2):93-98 Urinary stone distribution in Samawah: current status and variation with age and sex a cohort study Saad Hallawee 1* The aim of the study was to
More informationOriginal article: POSTMENOPAUSAL HORMONE AND THE RISK OF NEPHROLITHIASIS: A META-ANALYSIS
Original article: POSTMENOPAUSAL HORMONE AND THE RISK OF NEPHROLITHIASIS: A META-ANALYSIS Juan Yu 1, Binyan Yin 2,* 1 Eastern Operation room, Yantai Yuhuangding Hospital, Medical College of Qingdao University,
More informationMartin Konrad has documented that he has no relevant financial relationships to disclose or conflict of interest to resolve.
Martin Konrad has documented that he has no relevant financial relationships to disclose or conflict of interest to resolve. Nephrocalcinosis Clinical / Genetic Work-up and Outcome Martin Konrad University
More informationUrinary Calculus Disease
SYSTEMIC AND METABOLIC CONSIDERATION OF NEPHROLITHIASIS Marshall L. Stoller, M.D. Professor and Vice Chairman Department of Urology University of California San Francisco Urinary Calculus Disease Incidence:
More informationAssociation of serum biochemical metabolic panel with stone composition
bs_bs_banner International Journal of Urology (2015) 22, 195 199 doi: 10.1111/iju.12632 Original Article: Clinical Investigation Association of serum biochemical metabolic panel with stone composition
More informationCHILDHOOD CANCER SURVIVOR STUDY ANALYSIS CONCEPT PROPOSAL
CHILDHOOD CANCER SURVIVOR STUDY ANALYSIS CONCEPT PROPOSAL 1. Study title: Subsequent neoplasms among survivors of childhood cancer not previously treated with radiation 2. Working group and investigators:
More informationSchedule of taking calcium supplement and the risk of nephrolithiasis
Kidney International, Vol. 65 (2004), pp. 1835 1841 Schedule of taking calcium supplement and the risk of nephrolithiasis SOMNUEK DOMRONGKITCHAIPORN,WICHAI SOPASSATHIT, WASANA STITCHANTRAKUL, SURASING
More informationCalcium Oxalate Urolithiasis
Customer Name, Street Address, City, State, Zip code Phone number, Alt. phone number, Fax number, e-mail address, web site Calcium Oxalate Urolithiasis (Calcium Oxalate Stones in the Urinary Tract) Basics
More informationApproach to the Patient with Nephrolithiasis; The Stone Quiz. Farahnak Assadi* 1, MD
Education Article Iran J Ped Sep 2007; Vol 17 (No 3), Pp:283-292 Approach to the Patient with Nephrolithiasis; The Stone Quiz Farahnak Assadi* 1, MD 1. Pediatric Nephrologist, Rush University Medical Center,
More informationEffect of being overweight on urinary metabolic risk factors for kidney stone formation
NDT Advance Access published October 31, 2014 Nephrol Dial Transplant (2014) 0: 1 7 doi: 10.1093/ndt/gfu350 Original Article Effect of being overweight on urinary metabolic risk factors for kidney stone
More informationHypocalcemia 6/8/12. Normal value. Physiologic functions. Nephron a functional unit of kidney. Influencing factors in Calcium and Phosphate Balance
Normal value Hypocalcemia Serum calcium Total mg/dl Ionized mg/dl Cord blood 9.0 ~ 11.5 5.0 ~ 6.o New born (1 st 24 hrs) 9.0 ~ 10.6 4.3 ~ 5.1 24~ 48 hrs 7.0 ~12.0 4.0 ~4.7 Child 8.8 ~10.8 4.8 ~4.92 There
More informationScreening for and Assessment of Osteonecrosis in Oncology Patients. Sue C. Kaste, DO SPR Postgraduate Course 2015
Screening for and Assessment of Osteonecrosis in Oncology Patients Sue C. Kaste, DO SPR Postgraduate Course 2015 The author declares no potential conflicts of interest or financial disclosures Osteonecrosis
More informationUrine risk factors in children with calcium kidney stones and their siblings
http://www.kidney-international.org & 2012 International Society of Nephrology Urine risk factors in children with calcium kidney stones and their siblings Kristin J. Bergsland 1, Fredric L. Coe 1, Mark
More informationSummary. Olga Zając, Katarzyna Derwich, Katarzyna Stefankiewicz, Jacek Wachowiak. Rep Pract Oncol Radiother, 2007; 12(5):
Rep Pract Oncol Radiother, 2007; 12(5): 283-288 Preliminary Communication Received: 2007.03.27 Accepted: 2007.07.24 Published: 2007.10.18 Authors Contribution: A Study Design B Data Collection C Statistical
More informationAlterations of Renal and Urinary Tract Function
Alterations of Renal and Urinary Tract Function Chapter 29 Urinary Tract Obstruction Urinary tract obstruction is an interference with the flow of urine at any site along the urinary tract The obstruction
More informationThis Guideline in OUT OF DATE & has been ARCHIVED. Kidney stones epidemiology
nep_724.fm Page 26 Friday, January 26, 2007 6:34 PM Blackwell Publishing AsiaMelbourne, AustraliaNEPNephrology1320-5358 2006 The Authors; Journal compilation 2006 Asian Pacific Society of Nephrology200712S12630MiscellaneousKidney
More informationThe relationship between urinary tract infection and calcium excretion in children
The Turkish Journal of Pediatrics 2012; 54: 387-392 Original The relationship between urinary tract infection and calcium excretion in children Ayça Altıncık 1, Ferah Sönmez 2, Nevin Semerci 2, Çiğdem
More informationNutritional Considerations with Obesity and Bariatric Surgery. Presented by Dr. Ron Grabowski
Nutritional Considerations with Obesity and Bariatric Surgery Presented by Dr. Ron Grabowski January 25, 2010 Nutritional Considerations with Obesity and Bariatric Surgery Presented by Dr. Ron Grabowski
More informationUrinary Calculus Disease. Urinary Stones: Simplified Metabolic Evaluation. Urinary Calculus Disease. Urinary Calculus Disease 2/8/2008
Urinary Stones: Simplified Metabolic Evaluation Marshall L. Stoller, M.D. Professor and Vice Chairman Department of Urology University of California San Francisco Incidence: 7-21/10,000 3 men: 1 woman
More informationURINARY CALCIUM CREATININE RATIO AND HYPERCALCIURIA
URINARY CALCIUM CREATININE RATIO AND HYPERCALCIURIA B. Rath M.K. Aggarwal T.K. Mishra B. Talukdar N.S. Murthy B.C. Kabi ABSTRACT Random urine samples of 352 children in the age group of 5-12 yrs were studied
More informationAssessment of biochemical composition of renal calculi among patients visiting SVIMS, Tirupati
Original Research Article Assessment of biochemical composition of renal calculi among patients visiting SVIMS, Tirupati Sujana Nidumuru 1, Pampareddy B Kollur 2, Basawarajeshwari P Kollur 3, Sangappa
More informationContemporary Nutrition 6 th. th ed. Chapter 9 Minerals
Contemporary Nutrition 6 th th ed. Chapter 9 Minerals Minerals Various functions in the body Major Minerals Require >100 mg /day Calcium, phosphorus Trace Minerals Require < 100 mg/day Iron, zinc Bioavailability
More informationCNS Supervised Practice Experience Competencies
CNS Supervised Practice Experience Competencies The following are the competencies to be addressed by the supervised practice experience. Although in-depth experience is not expected for each competency,
More informationManaging patients with bulky cancers
SIOP PODC Supportive Care Education (ICON 2016) Presentation Date: 23 rd January 2016 Recording Link at www.cure4kids.org: https://www.cure4kids.org/ums/home/conference_rooms/enter.php?room=p2pjfjp8nha
More informationNIH Public Access Author Manuscript Osteoporos Int. Author manuscript; available in PMC 2011 January 8.
NIH Public Access Author Manuscript Published in final edited form as: Osteoporos Int. 2011 January ; 22(1): 345 349. doi:10.1007/s00198-010-1179-4. Does Dietary Protein Reduce Hip Fracture Risk in Elders?
More informationCorrespondence between stone composition and urine supersaturation in nephrolithiasis
Kidney International, Vol. 51 (1997), pp. 894 900 Correspondence between stone composition and urine supersaturation in nephrolithiasis JOAN H. PARKS, MARK COWARD, and REDRIC L. COE Program in Nephrology,
More informationCNS Practice Experience Plan For the CNS Candidate s Internal Use Only - Not Required for Submission
CNS Practice Experience Plan For the CNS Candidate s Internal Use Only - Not Required for Submission This is a document we provide to help you plan your Supervised Practice Experience. It is not required,
More information